Skip to main content
. Author manuscript; available in PMC: 2020 Sep 1.
Published in final edited form as: Pharmacol Res. 2019 Jul 25;147:104373. doi: 10.1016/j.phrs.2019.104373

Figure 9.

Figure 9.

Structures of selected MNPs subjected to profiling methods, BioMAP (arromycin), target-based profiling (isoarenarol, arenerol, brintonamide D, amantamide, grassystatin A and lyngbyastatin 1), high-content screening (bromophycolide A, microferrioxamine A–D, XR334, nocapyroneL and quinocinnolinomycins A–D) and whole-organism screening (diketopiperazine 1 and compound 2). Pharmacophores for protease inhibitors are highlighted.